Analytics

YTD Return (NAV)
+27.5%

+7.2% vs NBI benchmark

Alpha Generated
+14.4%

Annualized since inception

Win Rate
68%

Positions with positive returns

AI Signal Accuracy
78%

Trial Watchdog predictions

Monthly Returns vs Benchmark
Portfolio performance compared to NBI
Alpha Generation
Monthly excess returns over benchmark
Top Performers (YTD)
1

RVMD

Revolution Medicines

+42.8%
2

ARGX

Argenx

+28.4%
3

ALNY

Alnylam

+22.1%
Bottom Performers (YTD)
1

MRNA

Moderna

-18.5%
2

NBIX

Neurocrine

-4.2%
3

INCY

Incyte

+2.1%